España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Agios Pharmaceuticals
AGIO
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$42.65
0.63
1.50%
At Close: -
$42.65
0
0.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Get Report
Watch
Agios Pharmaceuticals (AGIO) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Agios Pharmaceuticals (NASDAQ:AGIO) Stock
Agios Pharmaceuticals Stock (NASDAQ: AGIO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, June 17, 2024
Expert Ratings For Agios Pharmaceuticals
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ag...
Benzinga Newsdesk
Saturday, June 15, 2024
Agios Announced Earlier Results From Its Pha...
Benzinga Newsdesk
Friday, June 14, 2024
Agio Pharmaceuticals Announces Poster Titled ...
Benzinga Newsdesk
Thursday, June 13, 2024
JP Morgan Reinstates Neutral on Agios Pharmac...
Benzinga Newsdesk
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Sunday, June 09, 2024
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
Lekha Gupta
Tuesday, June 04, 2024
Agios Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Goldman Sachs Maintains Neutral on Agios Phar...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Agios Pha...
Benzinga Newsdesk
Monday, June 03, 2024
Why Is Agios Pharmaceuticals Stock Trading Higher On Monday?
Vandana Singh
Agios Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Agios Pharmaceuticals Reports Phase 3 Results...
Benzinga Newsdesk
Tuesday, May 28, 2024
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Why Is Agios Pharmaceuticals Stock Trading Higher On Tuesday?
Vandana Singh
Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Agios Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Trading Halt: Halt status updated at 7:25:00 ...
Benzinga Newsdesk
Royalty Pharma Acquires Interest In Agios Pha...
Benzinga Newsdesk
Royalty Pharma To Acquire Rights To Agios' 15...
Benzinga Newsdesk
Trading Halt: Halted at 6:55:09 a.m. ET - Tra...
Benzinga Newsdesk
Thursday, May 16, 2024
Attention Biotech Investors - Stocks To Watch From RBC Global Healthcare Conference
Vandana Singh
Tuesday, May 14, 2024
Agios Pharmaceuticals Presents Clinical And T...
Benzinga Newsdesk
Friday, May 03, 2024
Goldman Sachs Maintains Neutral on Agios Phar...
Benzinga Newsdesk
Thursday, May 02, 2024
Agios Pharmaceuticals' Cash, Cash Equivalents...
Benzinga Newsdesk
Agios Pharmaceuticals Q1 2024 GAAP EPS $(1.45...
Benzinga Newsdesk
Tuesday, April 09, 2024
Cantor Fitzgerald Reiterates Overweight on Ag...
Benzinga Newsdesk
Friday, February 16, 2024
RBC Capital Maintains Outperform on Agios Pha...
Benzinga Newsdesk
Thursday, February 15, 2024
Agios Pharmaceuticals Q4 Sales $7.10M Miss $7...
Benzinga Newsdesk
Earnings Scheduled For February 15, 2024
Benzinga Insights
Wednesday, February 14, 2024
Earnings Preview: Agios Pharmaceuticals
Benzinga Insights
Monday, January 08, 2024
Agios Pharmaceuticals Announced Strong Cash Position Expected To Support Completion Of Ongoing Programs And Disciplined Pipeline Expansion At Least Into 2026
Charles Gross
Wednesday, January 03, 2024
Why Is Blood Disorder Focused Agios Pharmaceuticals Stock Trading Higher Today?
Vandana Singh
Market-Moving News for January 3rd
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Agios Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Agios Announces Phase 3 ENERGIZE Study Of Mit...
Benzinga Newsdesk
Sunday, December 10, 2023
Agios Presented Results Saturday From Phase 2 Portion Of RISE UP Pivotal Study In Sickle Cell Disease At ASH Meeting; Said Treatment With Mitapivat Demonstrated Statistically Significant Improvement In Hemoglobin Response Compared To Placebo
Charles Gross
Monday, November 20, 2023
Agios Announces Clinical Proof-of-Concept in ...
Benzinga Newsdesk
Friday, November 03, 2023
Goldman Sachs Maintains Neutral on Agios Phar...
Benzinga Newsdesk
Thursday, November 02, 2023
Agios Pharmaceuticals To Present Broad Set Of...
Benzinga Newsdesk
Agios Pharmaceuticals' Cash, Cash Equivalents...
Benzinga Newsdesk
Agios Pharmaceuticals Q3 EPS $(1.64) Beats $(...
Benzinga Newsdesk
Earnings Scheduled For November 2, 2023
Benzinga Insights
Tuesday, August 22, 2023
Agios Pharmaceuticals Insider Trades Send a Signal
Benzinga Insights
Thursday, August 10, 2023
Principal Accounting Officer At This Health Care Company Sells $74K of Stock
Benzinga Insights
Monday, August 07, 2023
JP Morgan Maintains Neutral on Agios Pharmace...
Benzinga Newsdesk
Thursday, August 03, 2023
Earnings Scheduled For August 3, 2023
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch